[1]
“Cutaneous Adverse Drug reactions: A Four-Year Study from Western Nepal”, JGMC-Nepal, vol. 10, no. 2, pp. 21–26, Aug. 2018, doi: 10.3126/jgmcn.v10i2.20804.